HESTER BIOSCIENCES
Back to Cashflow Statement
|
HESTER BIOSCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-52 Cr | ₹-26 Cr | ₹42 Cr | ₹112 Cr | ₹-18 Cr |
What is the latest Cash Flow from Financing Activities ratio of HESTER BIOSCIENCES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-52 Cr |
Mar2024 | ₹-26 Cr |
Mar2023 | ₹42 Cr |
Mar2022 | ₹112 Cr |
Mar2021 | ₹-18 Cr |
How is Cash Flow from Financing Activities of HESTER BIOSCIENCES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-52 Cr | Negative | |
Mar2024 | ₹-26 Cr | Negative | |
Mar2023 | ₹42 Cr | -62.56 | |
Mar2022 | ₹112 Cr | Positive | |
Mar2021 | ₹-18 Cr | - |
Compare Cash Flow from Financing Activities of peers of HESTER BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HESTER BIOSCIENCES | ₹1,855.7 Cr | 20.5% | 20.8% | -37.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
HESTER BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HESTER BIOSCIENCES | 20.5% |
20.8% |
-37.3% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses